急性呼吸衰竭。
Acute lung failure.
机构信息
Centre for Infection and Immunity, Queens University Belfast, Belfast, Northern Ireland.
出版信息
Semin Respir Crit Care Med. 2011 Oct;32(5):607-25. doi: 10.1055/s-0031-1287870. Epub 2011 Oct 11.
Abstract
Lung failure is the most common organ failure seen in the intensive care unit. The pathogenesis of acute respiratory failure (ARF) can be classified as (1) neuromuscular in origin, (2) secondary to acute and chronic obstructive airway diseases, (3) alveolar processes such as cardiogenic and noncardiogenic pulmonary edema and pneumonia, and (4) vascular diseases such as acute or chronic pulmonary embolism. This article reviews the more common causes of ARF from each group, including the pathological mechanisms and the principles of critical care management, focusing on the supportive, specific, and adjunctive therapies for each condition.
摘要
肺衰竭是重症监护病房最常见的器官衰竭。急性呼吸衰竭（ARF）的发病机制可分为（1）神经肌肉源性，（2）继发于急性和慢性阻塞性气道疾病，（3）肺泡过程，如心源性和非心源性肺水肿和肺炎，以及（4）血管疾病，如急性或慢性肺栓塞。本文从每组中回顾 ARF 的更常见原因，包括病理机制和重症监护管理原则，重点介绍每种情况的支持、特定和辅助治疗。
相似文献
1
Acute lung failure.
Semin Respir Crit Care Med. 2011 Oct;32(5):607-25. doi: 10.1055/s-0031-1287870. Epub 2011 Oct 11.
2
Multi-organ mechanical support for acute respiratory failure with renal failure-Considerations for future research.
Clin Respir J. 2019 Sep;13(9):598-599. doi: 10.1111/crj.13066. Epub 2019 Aug 23.
3
Pathophysiology and Management of Acute Respiratory Distress Syndrome in Children.
Pediatr Clin North Am. 2017 Oct;64(5):1017-1037. doi: 10.1016/j.pcl.2017.06.004.
4
[Etiology and pathogenesis of acute respiratory failure].
Medicina (Kaunas). 2004;40(3):286-94.
5
Surfactant therapy for acute respiratory distress in children.
Acta Biomed. 2013;84 Suppl 1:18-21.
6
Prognostic factors, clinical course, and hospital outcome of patients with chronic obstructive pulmonary disease admitted to an intensive care unit for acute respiratory failure.
Crit Care Med. 2002 Jul;30(7):1610-5. doi: 10.1097/00003246-200207000-00035.
7
Acute respiratory failure.
Crit Care Clin. 2013 Apr;29(2):167-83. doi: 10.1016/j.ccc.2012.12.004. Epub 2013 Feb 11.
8
Mobile critical care recovery program (m-CCRP) for acute respiratory failure survivors: study protocol for a randomized controlled trial.
Trials. 2018 Feb 7;19(1):94. doi: 10.1186/s13063-018-2449-2.
9
The epidemiology of acute respiratory failure in critically ill patients(*).
Chest. 2002 May;121(5):1602-9. doi: 10.1378/chest.121.5.1602.
10
Lung Ultrasound for the Diagnosis and Management of Acute Respiratory Failure.
Lung. 2020 Feb;198(1):1-11. doi: 10.1007/s00408-019-00309-1. Epub 2020 Jan 1.
引用本文的文献
1
Mucoactive agent use in adult UK Critical Care Units: a survey of health care professionals' perception, pharmacists' description of practice, and point prevalence of mucoactive use in invasively mechanically ventilated patients.
PeerJ. 2020 May 4;8:e8828. doi: 10.7717/peerj.8828. eCollection 2020.
2
HIF and HOIL-1L-mediated PKCζ degradation stabilizes plasma membrane Na,K-ATPase to protect against hypoxia-induced lung injury.
Proc Natl Acad Sci U S A. 2017 Nov 21;114(47):E10178-E10186. doi: 10.1073/pnas.1713563114. Epub 2017 Nov 6.
3
High-flow nasal oxygen versus noninvasive ventilation for hypoxemic respiratory failure: Do we know enough?
Ann Thorac Med. 2016 Jul-Sep;11(3):163-6. doi: 10.4103/1817-1737.185760.
4
Lung Edema Clearance: Relevance to Patients with Lung Injury.
Rambam Maimonides Med J. 2015 Jul 30;6(3):e0025. doi: 10.5041/RMMJ.10210.
5
Early exercise rehabilitation of muscle weakness in acute respiratory failure patients.
Exerc Sport Sci Rev. 2013 Oct;41(4):208-15. doi: 10.1097/JES.0b013e3182a4e67c.
本文引用的文献
1
Inhaled nitric oxide for acute respiratory distress syndrome and acute lung injury in adults and children: a systematic review with meta-analysis and trial sequential analysis.
Anesth Analg. 2011 Jun;112(6):1411-21. doi: 10.1213/ANE.0b013e31820bd185. Epub 2011 Mar 3.
2
Role of noninvasive ventilation in acute lung injury/acute respiratory distress syndrome: a proportion meta-analysis.
Respir Care. 2010 Dec;55(12):1653-60.
3
Diagnosis and management of autoimmune myasthenia gravis.
Clin Drug Investig. 2011;31(1):1-14. doi: 10.2165/11584740-000000000-00000.
4
Effect of oral β-blocker on short and long-term mortality in patients with acute respiratory failure: results from the BASEL-II-ICU study.
Crit Care. 2010;14(6):R198. doi: 10.1186/cc9317. Epub 2010 Nov 3.
5
Genetics of acute lung injury: past, present and future.
Minerva Anestesiol. 2010 Oct;76(10):860-4. Epub 2010 Jul 1.
6
Therapeutic potential of mesenchymal stem cells for severe acute lung injury.
Chest. 2010 Oct;138(4):965-72. doi: 10.1378/chest.10-0518.
7
Neuromuscular blockers in early acute respiratory distress syndrome.
N Engl J Med. 2010 Sep 16;363(12):1107-16. doi: 10.1056/NEJMoa1005372.
8
Management of submassive pulmonary embolism.
Circulation. 2010 Sep 14;122(11):1124-9. doi: 10.1161/CIRCULATIONAHA.110.961136.
9
Acute pulmonary embolism.
N Engl J Med. 2010 Jul 15;363(3):266-74. doi: 10.1056/NEJMra0907731. Epub 2010 Jun 30.
10
Intravenous immunoglobulin for Guillain-Barré syndrome.
Cochrane Database Syst Rev. 2010 Jun 16(6):CD002063. doi: 10.1002/14651858.CD002063.pub4.
Zotero 插件